FindTrial
Sign In

Remicade 100 mg powder for concentrate for solution for infusion.

DRUG5 trials

Sponsors

Biocompatibles UK Limited, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Region Skane, Isala Klinieken Stichting, Sint Maartenskliniek Stichting

Conditions

Crohn´s diseaseHepatocellular CarcinomaInflammatory bowel diseaseOncologyRheumatic diseaseRheumatoid arthritisRheumatoid arthritis according to 2010 criteriaUlcerative colitis

Phase 2

An Open-Label, Prospective, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of TheraSphere™ Followed by Durvalumab (Imfinzi®) with Tremelimumab (Imjudo®) for Hepatocellular Carcinoma (HCC)
Active, not recruitingCTIS2023-508945-41-00
Biocompatibles UK LimitedHepatocellular Carcinoma
Start: 2023-10-11Target: 81Updated: 2026-01-27

Phase 4

Stopping anti-TNF treatment in Crohn's and Colitis patients in remission
RecruitingCTIS2024-513299-17-00
Region SkaneCrohn´s disease, Ulcerative colitis
Start: 2017-05-05Target: 350Updated: 2024-09-09
PeRsonalIzed MEdicine in Rheumatoid Arthritis (PRIMERA trial): a multicenter, open-label, randomized controlled trial comparing usual care with a tailor-made approach
Not yet recruitingCTIS2024-511530-12-01
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rheumatoid arthritis according to 2010 criteria
Target: 300Updated: 2024-10-01
Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study (MINUTE)
Not yet recruitingCTIS2024-518878-14-01
Isala Klinieken StichtingInflammatory bowel disease, Oncology, Rheumatic disease
Target: 1261Updated: 2025-12-18
DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial
Not yet recruitingCTIS2026-525316-33-00
Sint Maartenskliniek StichtingRheumatoid arthritis
Target: 202Updated: 2026-06-09